Patents
Patents for C07D 493 - Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system (17,376)
12/2002
12/05/2002US20020183353 For therapy of depression, obsessive compulsive disorder, panic attacks, generalized anxiety disorder, social anxiety disorder, sexual dysfunction, eating disorders, obesity, addictive disorders caused by ethanol or cocaine abuse
12/05/2002US20020183346 Tricyclic androgen receptor modulator compounds and methods
12/05/2002US20020183310 For therapy or inhibiting osteoporosis or inhibiting bone demineralization, inflammatory bowel disease, Crohn's disease, ulcerative proctitis, or colitis in mammal
12/05/2002US20020182581 Treating blood or blood products with compounds which have a mustard, aziridinium or aziridine group and a nucleic acid binding group
12/05/2002US20020182232 Naphthofurandione dyes
12/05/2002CA2448528A1 Product comprising mikanolide, dihydromikanolide or an analogue thereof combined with another anti-cancer agent for therapeutic use in cancer treatment
12/04/2002EP1262482A1 Novel compound having antimalarial activity
12/04/2002EP1261333A1 Method of treating and diagnosing sleep disordered breathing and means for carrying out the method
12/04/2002EP1045841B1 Novel genipin derivative having liver protection activity
12/04/2002EP0663915B1 Syntheses of d-chiro-3-inosose and (+)-d-chiro-inositol
12/03/2002US6489364 From l-mannonic-gamma-lactone intermediates; for prophylaxis of hiv/aids hiv
12/03/2002CA2052365C Substituted cyclopentenyl-oxabicyclooctanes, cyclopentenyl-formylcyclohexenes, cyclopentenyl-hydroxymethyl cyclohexenes and camphonyl spirocyclooxaoctane-containing compositions, organoleptic uses thereof and process for preparing same
11/2002
11/28/2002WO2002094836A2 Methods for preparation and use of psorospermin analogs
11/28/2002WO2002094809A1 3-quinoline-2-(1h)-ylideneindolin-2-one derivatives
11/28/2002WO2002094196A2 Method of treatment for cancers associated with elevated
11/28/2002US20020177615 Pharmaceutical compositions, dosage forms and methods for oral administration of epothilones
11/28/2002US20020177578 3-hydroxy-4-methoxypyridine-2-carboxyamides N-substituted with a benzyl 9-member dilactone ring
11/28/2002US20020174596 Reacting the isosorbide with epoxy containing compounds
11/28/2002CA2489768A1 Methods for preparation and use of psorospermin analogs
11/28/2002CA2448076A1 3-quinoline-2-(1h)-ylideneindolin-2-one derivatives
11/28/2002CA2447066A1 Method of treatment for cancers associated with elevated
11/27/2002EP1260510A1 Fluorescent probes for the quantitation of zinc
11/27/2002EP1260498A1 Novel color former and recording material
11/27/2002EP1259490A2 Synthesis of epothilones, intermediates thereto and analogues thereof
11/27/2002EP1123289B1 Oxobenzofuranylide-dihydroindolones
11/27/2002EP0825982B1 Alkyl dihalogenated phenyl-substituted ketoenols useful as pesticides and herbicides
11/27/2002EP0777492A4 Combinatorial libraries of substrate-bound cyclic organic compounds
11/27/2002CN1381459A Deacidified gingko leaf and its extract and its preparing process and application
11/27/2002CN1094940C Taxol derivative with antineoplastic activity
11/27/2002CN1094938C Block oligomers containing 1-hydrocarbyloxy-2,2,6,6-tetramethyl-4-piperidyl group as stabilizer for organic materials
11/26/2002US6486360 Singlet oxygen oxidation of organic substrates
11/26/2002US6486343 Substituted phenyl keto enols as pesticides and herbicides
11/26/2002US6486330 4-oxatricyclo[4.3.1.1 3,8]undecan-5-one derivative and process for producing the same
11/26/2002US6486199 Spiro and dispiro 1,2,4-trioxolane antimalarials
11/26/2002US6486198 Compounds and methods for the treatment of post traumatic stress disorder
11/26/2002US6486197 Substance ft-0554 and process for producing the same
11/26/2002US6486195 Thermodynamically stable crystal form of 4″-deoxy-4″-epi-methylamino avermectin B1a/B1b benzoic acid salt and processes for its preparation
11/26/2002US6485984 Calixcrown derivatives, a process for the preparation thereof, a self-assembled mono-layer of the calixcrown derivatives prepared by using the same and a process for immobilizing a protein mono-layer by using the self-assembled mono-layer of the calixcrown derivatives
11/21/2002WO2002092600A1 Retinol derivatives potentiation of active substances by micellar preparation
11/21/2002WO2002092595A1 Broadspectrum 2-amino-benzoxazole sulfonamide hiv protease inhibitors
11/21/2002WO2002092594A1 Substituted 4h-chromenes and analogs as activators of caspases and inducers of apoptosis and the use thereof
11/21/2002WO2002092564A2 Synthesis of cyclopentadiene derivatives
11/21/2002WO2002092076A1 Substituted coumarins and quinolines as caspases activators
11/21/2002US20020173473 Organic compounds
11/21/2002US20020173445 Selective androgen receptor modulators and methods for their identification, design and use
11/20/2002EP1257558A1 Methods for synthesis of alpha-d-gal (1- 3) gal-containing oligosaccharides
11/20/2002EP1257519A1 Chemical transformation of substrates using nonmetallic, organic catalyst compositions
11/20/2002EP0892780B1 M-AMIDINO PHENYL ANALOGS AS FACTOR Xa INHIBITORS
11/19/2002US6482943 Quinones as disease therapies
11/19/2002CA2061706C Pyranylphenyl hydroxyalkylnaphthoic acids as inhibitors of leukotriene biosynthesis
11/14/2002WO2002090342A1 Chromene compound
11/14/2002WO2002042310A3 Oxabicyclo[2.2.1]heptane derivatives as pesticidal agents
11/14/2002US20020169330 Method for production of pyromellitic dianhydride
11/14/2002US20020168436 Decursinol or derivative thereof as analgesic agent
11/13/2002EP1256563A1 Method for production of pyromellitic dianhydride
11/13/2002EP1255840A2 Gene cluster encoding a nystatin polyketide synthase and its manipulation and utility
11/13/2002CN1379752A Aromatic di-ceto-derivatives use as glucose-6-phosphate translocase inhibitors
11/13/2002CN1379029A Process for extracting ginkgolectone AB
11/12/2002CA2088289C Pharmaceutically active composition extracted from tanacetum parthenium, process for its extraction, and pharmaceutical composition containing same
11/07/2002WO2002088137A1 Pkb-3564 substance with neovascularization inhibitory activity
11/07/2002WO2002088136A2 Antidepressant azaheterocyclylmethyl derivatives of 1,4,5-trioxa-phenanthrene
11/07/2002WO2002088135A1 Antidepressant azaheterocyclylmethyl derivatives of oxaheterocycle-fused-[1,4]-benzodioxans
11/07/2002WO2002088126A1 Triazolopyrimidines
11/07/2002WO2002088107A1 Nitrogenous fused-ring compound having pyrazolyl group as substituent and medicinal composition thereof
11/07/2002WO2002087590A1 Treatment of psychotic disorders comprising co-therapy with anticonvulsant derivatives and atypical antipsychotics
11/07/2002US20020165415 Synthesis of epothilones
11/07/2002US20020165399 Interphenylene 7-oxabicyclic [2.2.1] heptane oxazoles as prostaglandin F2a antagonists
11/07/2002US20020165257 For patients exhibiting resistance to oncology and chemotherapy with taxanes; antiproliferative agents
11/07/2002US20020165256 Fermentative preparation process for and crystal forms of cytostatics
11/07/2002US20020165096 Applying to weeds
11/07/2002CA2445543A1 Antidepressant azaheterocyclylmethyl derivatives of oxaheterocycle-fused-¬1,4|-benzodioxans
11/07/2002CA2445528A1 Treatment of psychotic disorders comprising co-therapy with anticonvulsant derivatives and atypical antipsychotics
11/07/2002CA2445376A1 Substance rkb-3564 having angiogenesis inhibitory action
11/06/2002EP1254902A1 Agents correcting gene expression regulatory error
11/05/2002US6476242 2-aroyl-4-acyl paclitaxel (Taxol) analogs
11/05/2002US6476238 Purification method for obtaining high-purity PMDA
11/05/2002US6476066 Anti-first-pass effect compounds
11/05/2002US6476065 Antitumor agents
10/2002
10/31/2002WO2001056563A9 Adamantyl derivatives as anti-cancer agents
10/31/2002US20020161135 Crosslinked polyorthoester
10/31/2002US20020161034 Spiro-pyran compounds; use as pesticides and herbicides
10/31/2002US20020160028 Anti-aging effect, whitening effect and hair-seeding effect
10/31/2002DE10121162A1 Triazolopyrimidine Triazolopyrimidines
10/30/2002EP1252893A1 Medicine containing anemonin as effective component for treating aseptic inflammation
10/30/2002EP0956280B1 Non-volatile phenylglyoxalic esters
10/29/2002US6473512 Apparatus and method for a custom soft-solid hearing aid
10/29/2002US6472227 A fluorescein moiety is included in the tracer, while a poly(amino acid) forms a part of the immunogen for determining the amount of barbiturate in fluids, especially biological fluids such as serum, plasma or urine
10/24/2002WO2002083657A2 Broadspectrum 2-(substituted-amino)-benzothiazole sulfonamide hiv protease inhibitors
10/24/2002WO2002070472A3 Triptolide prodrugs having high aqueous solubility
10/24/2002WO2002058639A3 Pyranoflavonoid compounds and their use as estrogen receptor modulators
10/24/2002WO2002055522A3 Novel multi-ring organic compounds for regulating gut motility and food intake
10/24/2002WO2002050065A3 Pyrazole compounds useful as protein kinase inhibitors
10/24/2002US20020156289 Synthesis of epothilones
10/24/2002US20020156126 FT-0554 substance and its production
10/22/2002US6469196 Dialkyl phenyl halide-substituted keto-enols for use as herbicides and pesticides
10/22/2002US6469184 Coupling a cyclopentenone with a cyclic carbonyl ylide dipole
10/22/2002US6469182 Intermediates in the preparation of macrocyclic analogs
10/22/2002US6469076 Chromene compounds
10/22/2002US6469052 Compounds for the photodecontamination of pathogens in blood
10/22/2002US6469051 Diaminorhodamine derivative